🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery

RecruitingNAAges 18 Years - anyFemaleWeill Medical College of Cornell University
NCT04891510 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to learn whether there is a superior fat processing method in terms of graft retention in breast reconstruction after mastectomy.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Female; * Documented history of previous breast surgery (either complete or partial mastectomy); * Available harvest sites for fat grafting as documented by plastic surgeon; * BMI \> 20; * Anticipated harvested fat volume \> 50cc; * Competency and willingness to provide consent Exclusion Criteria: * Suspected or known to be pregnant
💊

What it tests

  • REVOLVE Advanced Adipose System
  • LipoGrafter
  • Viality
📍

Where

1 site
New York Presbyterian - Weill Cornell Medicine
New York, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy